Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Marson, Asya Al-Kharusi, M. Alwaidh, R. Appleton, G. Baker, D. Chadwick, C. Cramp, O. Cockerell, P. Cooper, J. Doughty, B. Eaton, C. Gamble, P. Goulding, S. Howell, A. Hughes, M. Jackson, A. Jacoby, M. Kellett, Geoff Lawson, J. Leach, P. Nicolaides, R. Roberts, P. Shackley, Jing Shen, David Smith, P. Smith, Catrin Smith, A. Vanoli, P. Williamson (2007)
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialThe Lancet, 369
E. Dogan, B. Usta, Rengin Bilgen, Y. Şenol, B. Aktekin (2008)
Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: A prospective study ın adult and elderly patients with newly diagnosed partial epilepsyEpilepsy & Behavior, 13
R. Soffietti, P. Cornu, J. Delattre, R. Grant, F. Graus, W. Grisold, J. Heimans, J. Hildebrand, P. Hoskin, M. Kalljo, P. Krauseneck, C. Marosi, T. Siegal, C. Vecht (2006)
EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task ForceEuropean Journal of Neurology, 13
T. Browne (1998)
Pharmacokinetics of antiepileptic drugsNeurology, 51
C. Benit, C. Vecht (2016)
Seizures and cancer: drug interactions of anticonvulsants with chemotherapeutic agents, tyrosine kinase inhibitors and glucocorticoids.Neuro-oncology practice, 3 4
M. Kerkhof, Janneke Dielemans, M. Breemen, H. Zwinkels, R. Walchenbach, M. Taphoorn, C. Vecht (2013)
Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme.Neuro-oncology, 15 7
MJ Glantz, BF Cole, PA Forsyth, LD Recht, PY Wen, MC Chamberlain (2000)
Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of NeurologyNeurology, 54
K Lote, AE Stenwig, K Skullerud, H Hirschberg (1998)
Original paper prevalence and prognostic significance of epilepsy in patients with gliomasEur J Cancer, 34
S. Oberndorfer, M. Piribauer, C. Marosi, H. Lahrmann, P. Hitzenberger, W. Grisold (2005)
P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapyJournal of Neuro-Oncology, 72
B Cacho-Diaz, NA Lorenzana-Mendoza (2017)
Valproic acid in patients with glioma: a small reviewClin Oncol, 2
M. Maschio, L. Dinapoli, A. Vidiri, A. Pace, A. Fabi, A. Pompili, Maria Carapella, B. Jandolo (2009)
The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepineJournal of Experimental & Clinical Cancer Research : CR, 28
M. Glantz, M. Glantz, B. Cole, B. Cole, P. Forsyth, Lawrence Recht, L. Recht, P. Wen, P. Wen, M. Chamberlain, M. Chamberlain, S. Grossman, J. Cairncross (2000)
Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumorsNeurology, 54
J. Koekkoek, M. Kerkhof, L. Dirven, J. Heimans, J. Reijneveld, M. Taphoorn (2015)
Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic review.Neuro-oncology, 17 7
A. Mauro, C. Bomprezzi, S. Morresi, L. Provinciali, F. Formica, M. Iacoangeli, M. Scerrati (2007)
Prevention of early postoperative seizures in patients with primary brain tumors: preliminary experience with oxcarbazepineJournal of Neuro-Oncology, 81
T. Wegman-Ostrosky, N. Reynoso-Noverón, S. Mejía-Pérez, T. Sánchez-Correa, R. Álvarez-Gómez, S. Vidal-Millán, B. Cacho-Díaz, J. Śanchez-Corona, L. Herrera-Montalvo, T. Corona-Vázquez (2016)
Clinical prognostic factors in adults with astrocytoma: Historic cohortClinical Neurology and Neurosurgery, 146
K. Yap, W. Chui, A. Chan (2008)
Drug interactions between chemotherapeutic regimens and antiepileptics.Clinical therapeutics, 30 8
Edward Avila, M. Chamberlain, D. Schiff, J. Reijneveld, T. Armstrong, R. Rudà, P. Wen, M. Weller, J. Koekkoek, S. Mittal, Y. Arakawa, A. Choucair, J. González-Martínez, D. Macdonald, R. Nishikawa, Aashit Shah, C. Vecht, P. Warren, M. Bent, L. Deangelis (2017)
Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials.Neuro-oncology, 19 1
M. Breemen, E. Wilms, C. Vecht (2007)
Epilepsy in patients with brain tumours: epidemiology, mechanisms, and managementThe Lancet Neurology, 6
C. Happold, T. Gorlia, O. Chinot, M. Gilbert, L. Nabors, W. Wick, S. Pugh, M. Hegi, T. Cloughesy, P. Roth, D. Reardon, J. Perry, M. Mehta, R. Stupp, M. Weller (2016)
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34 7
Xuling Lin, L. Deangelis (2015)
Treatment of Brain Metastases.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33 30
A. Beutler, Side Li, R. Nicol, M. Walsh (2005)
Carbamazepine is an inhibitor of histone deacetylases.Life sciences, 76 26
C. Scripture, W. Figg (2006)
Drug interactions in cancer therapyNature Reviews Cancer, 6
M. Riva, A. Salmaggi, E. Marchioni, A. Silvani, G. Tomei, L. Lorusso, R. Merli, F. Imbesi, A. Russo, For Group (2006)
Tumour-associated epilepsy: clinical impact and the role of referring centres in a cohort of glioblastoma patients. A multicentre study from the Lombardia Neurooncology GroupNeurological Sciences, 27
H. Gefroh-Grimes, B. Gidal (2016)
Antiepileptic drugs in patients with malignant brain tumor: beyond seizures and pharmacokineticsActa Neurologica Scandinavica, 133
A. Marson, Asya Al-Kharusi, M. Alwaidh, R. Appleton, G. Baker, D. Chadwick, C. Cramp, O. Cockerell, P. Cooper, J. Doughty, B. Eaton, C. Gamble, P. Goulding, S. Howell, A. Hughes, M. Jackson, A. Jacoby, M. Kellett, Geoff Lawson, J. Leach, P. Nicolaides, R. Roberts, P. Shackley, Jing Shen, David Smith, P. Smith, Catrin Smith, A. Vanoli, P. Williamson (2007)
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trialThe Lancet, 369
Gagandeep Singh, J. Rees, Josemir Sander (2006)
Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatmentJournal of Neurology, Neurosurgery & Psychiatry, 78
G. Guthrie, S. Eljamel (2013)
Impact of particular antiepileptic drugs on the survival of patients with glioblastoma multiforme.Journal of neurosurgery, 118 4
S. Plotkin, Patrick Wen, Patrick Wen (2011)
Neurologic Complications of Cancer Therapy
C. Neef, Ingrid Straaten (1988)
An interaction between cytostatic and anticonvulsant drugsClinical Pharmacology & Therapeutics, 43
K. Taing, T. O’Brien, D. Williams, C. French (2017)
Anti-Epileptic Drug Combination Efficacy in an In Vitro Seizure Model – Phenytoin and Valproate, Lamotrigine and ValproatePLoS ONE, 12
K. Lote, Stenwig Ae, K. Skullerud, H. Hirschberg (1998)
Prevalence and prognostic significance of epilepsy in patients with gliomas.European journal of cancer, 34 1
M. Maschio, L. Dinapoli, F. Sperati, A. Fabi, Andrea Pace, A. Vidiri, Paola Muti (2012)
Oxcarbazepine monotherapy in patients with brain tumor-related epilepsy: open-label pilot study for assessing the efficacy, tolerability and impact on quality of lifeJournal of Neuro-Oncology, 106
J. Pallud, E. Audureau, M. Blonski, N. Sanai, L. Bauchet, D. Fontaine, E. Mandonnet, E. Dezamis, D. Psimaras, J. Guyotat, P. Peruzzi, P. Page, B. Gal, E. Párraga, M. Baron, Michaela Vlaicu, R. Guillevin, B. Devaux, H. Duffau, L. Taillandier, L. Capelle, G. Huberfeld (2014)
Epileptic seizures in diffuse low-grade gliomas in adults.Brain : a journal of neurology, 137 Pt 2
K. Jaeckle, K. Ballman, A. Furth, J. Buckner (2009)
Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastomaNeurology, 73
Edward Chang, M. Potts, G. Keles, K. Lamborn, Susan Chang, N. Barbaro, Mitchel Berger (2008)
Seizure characteristics and control following resection in 332 patients with low-grade gliomas.Journal of neurosurgery, 108 2
M. Riva (2016)
Epilepsy in neuro-oncology: a reviewEuropean Journal of Oncology, 21
S. Nolan, C. Smith, Jennifer Weston, A. Marson (2016)
Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.The Cochrane database of systematic reviews, 11
G. Huberfeld, C. Vecht (2016)
Seizures and gliomas — towards a single therapeutic approachNature Reviews Neurology, 12
Hao Chen, Jonathon Judkins, Cheddhi Thomas, Meijing Wu, L. Khoury, C. Benjamin, D. Pacione, J. Golfinos, P. Kumthekar, Farhad Ghamsari, Li Chen, P. Lein, D. Chetkovich, M. Snuderl, C. Horbinski (2017)
Mutant IDH1 and seizures in patients with gliomaNeurology, 88
J. Chalk, K. Ridgeway, T. Brophy, J. Yelland, M. Eadie (1984)
Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients.Journal of Neurology, Neurosurgery & Psychiatry, 47
C. Vecht, M. Kerkhof, A. Duran-Peña (2014)
Seizure prognosis in brain tumors: new insights and evidence-based management.The oncologist, 19 7
J. Villemure, N. Tribolet (1996)
Epilepsy in patients with central nervous system tumorsCurrent Opinion in Neurology, 9
Background Seizures in cancer patients may occur as a result of CNS primary or metastatic tumor, brain surgery, vascular disease, pharmacologic treatment (including chemotherapy), radiation therapy, or metabolic disorders. The aims of the study were to a) determine whether seizures in cancer patients have prognostic implications and b) study patient outcome based on the antiepileptic drug used. Method This is a prospective comparative study that included adult cancer patients with and without seizures from May 2010 to November 2016 seen by the neuro-oncology unit at a cancer referral center. Variables included age, gender, oncologic characteristics, seizure features, treatment, and outcome. Parametric and non-parametric tests were used to compare groups, and Kaplan–Meier curves with the log-rank test were used to analyze survival. Cox multivariate regression tests were used to describe survival and compare groups. Results A total of 823 patients were included; 419 (51%) patients had at least one seizure and were compared with 404 (49%) who did not experience seizures. Of the seizure group, 53% had brain metastases, 36% did not have a brain tumor, and 11% had a primary brain tumor. No survival differences were noted among patients with brain metastases or primary tumor with or without seizures.
Clinical and Translational Oncology – Springer Journals
Published: Jun 4, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.